(Q35097652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Beta-thalassaemia: emergence of new and improved iron chelators for treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Cynthia Wong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Biochemistry & Cell Biology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1144-1149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

3-Hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron-chelating agents for the treatment of iron overload disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

The therapeutic potential of iron chelators

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

The controversial role of deferiprone in the treatment of thalassemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Multifunctional antioxidant activity of HBED iron chelator

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Combined therapy with deferiprone and desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2803%2900046-3

7 January 2021

10.1016/S1357-2725(03)00046-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12672484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference